NBIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $39,819,282.26

Neurocrine Biosciences Insider Trading History Chart

Neurocrine Biosciences Share Price & Price History

^$134.07

▲ +2.29 (1.74%)

As of 05/4/2026 04:00 PM ET

Days: 30 | 90 | 365

Neurocrine Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/16/2026	Kyle Gano	CEO	Sell	36,400	$132.70	$4,830,280.00	140,407
12/16/2025	Leslie V Norwalk	Director	Sell	1,190	$155.09	$184,557.10	6,239
12/15/2025	Leslie V Norwalk	Director	Sell	5,000	$152.23	$761,150.00	7,429
12/8/2025	Darin Lippoldt	Insider	Sell	4,376	$159.65	$698,628.40	43,405
11/25/2025	George J Morrow	Director	Sell	15,000	$143.37	$2,150,550.00	7,068
11/5/2025	William H. Rastetter	Director	Sell	18,000	$151.82	$2,732,760.00	40,360
11/4/2025	Kyle Gano	CEO	Sell	300	$141.97	$42,591.00	140,407
8/7/2025	Kevin Charles Gorman	Director	Sell	106,322	$126.41	$13,440,164.02	514,596
7/10/2025	Ingrid Delaet	Insider	Sell	457	$135.00	$61,695.00	4,730
7/9/2025	Jude Onyia	Insider	Sell	59,819	$130.46	$7,803,986.74	18,289
7/2/2025	Jude Onyia	Insider	Sell	20,362	$130.13	$2,649,707.06	18,289
5/27/2025	Kevin Charles Gorman	Director	Sell	9,613	$120.38	$1,157,212.94	514,596
5/5/2025	William H. Rastetter	Director	Sell	30,000	$110.20	$3,306,000.00	37,491
2/13/2025	Julie Cooke	Insider	Sell	1,551	$116.78	$181,125.78	19,544
2/13/2025	Kevin Charles Gorman	Director	Sell	5,844	$116.69	$681,936.36	521,618
2/13/2025	Matt Abernethy	CFO	Sell	2,558	$116.86	$298,927.88	34,775
2/10/2025	Julie Cooke	Insider	Sell	700	$118.28	$82,796.00	18,831
2/10/2025	Kevin Charles Gorman	Director	Sell	2,274	$118.37	$269,173.38	519,074
2/10/2025	Kyle Gano	CEO	Sell	980	$118.39	$116,022.20	137,658
2/3/2025	Ingrid Delaet	Insider	Sell	623	$149.29	$93,007.67	3,442
1/31/2025	Julie Cooke	Insider	Sell	1,740	$152.89	$266,028.60	18,202
1/31/2025	Kevin Charles Gorman	Director	Sell	2,707	$152.92	$413,954.44	517,030
1/31/2025	Kyle Gano	CEO	Sell	1,541	$152.87	$235,572.67	136,778
1/31/2025	Matt Abernethy	CFO	Sell	1,283	$152.87	$196,132.21	32,681
1/27/2025	Kevin Charles Gorman	Director	Sell	146,105	$149.46	$21,836,853.30	514,596
1/15/2025	Kyle Gano	CEO	Sell	65,000	$141.50	$9,197,500.00	135,392
12/31/2024	Ingrid Delaet	Insider	Sell	272	$138.10	$37,563.20	2,507
12/17/2024	Ingrid Delaet	Insider	Sell	1,091	$135.00	$147,285.00	2,507
11/29/2024	Jude Onyia	Insider	Sell	2,331	$126.29	$294,381.99	15,449
8/15/2024	William H. Rastetter	Director	Sell	14,250	$146.69	$2,090,332.50	37,491
8/13/2024	Gary A. Lyons	Director	Sell	11,570	$150.43	$1,740,475.10	119,047
8/13/2024	Ingrid Delaet	Insider	Sell	7,143	$150.10	$1,072,164.30	2,507
8/13/2024	Matt Abernethy	CFO	Sell	14,100	$150.38	$2,120,358.00	31,528
8/6/2024	Ingrid Delaet	Insider	Sell	273	$147.70	$40,322.10	6,607
8/1/2024	Julie Cooke	Insider	Sell	12,632	$153.26	$1,935,980.32	18,202
7/16/2024	Gary A. Lyons	Director	Sell	930	$150.03	$139,527.90	119,047
7/16/2024	Julie Cooke	Insider	Sell	900	$150.04	$135,036.00	18,202
7/1/2024	Julie Cooke	Insider	Sell	10,000	$140.19	$1,401,900.00	18,202
5/29/2024	Stephen A. Sherwin	Director	Sell	40,000	$133.46	$5,338,400.00	26,504
5/17/2024	Shalini Sharp	Director	Sell	1,106	$141.90	$156,941.40	994
5/15/2024	Matt Abernethy	CFO	Sell	15,000	$140.24	$2,103,600.00	31,528
5/14/2024	Gary A. Lyons	Director	Sell	12,500	$135.63	$1,695,375.00	116,947
5/6/2024	Ingrid Delaet	Insider	Sell	273	$140.55	$38,370.15	7,507
4/15/2024	Eric Benevich	Insider	Sell	19,818	$133.36	$2,642,928.48	40,778
3/21/2024	Ingrid Delaet	Insider	Sell	5,000	$145.06	$725,300.00	7,507
3/14/2024	Eric Benevich	Insider	Sell	75,000	$139.38	$10,453,500.00	40,778
3/14/2024	George J. Morrow	Director	Sell	40,000	$139.42	$5,576,800.00
3/11/2024	Ingrid Delaet	Insider	Sell	200	$140.00	$28,000.00	7,507
3/11/2024	Richard F. Pops	Director	Sell	100	$140.00	$14,000.00	29,512
3/8/2024	Ingrid Delaet	Insider	Sell	1,800	$140.03	$252,054.00	7,507
3/8/2024	Richard F. Pops	Director	Sell	1,700	$140.05	$238,085.00	29,512
2/29/2024	Ingrid Delaet	Insider	Sell	273	$135.51	$36,994.23	7,507
2/27/2024	Leslie V. Norwalk	Director	Sell	8,000	$135.67	$1,085,360.00
2/20/2024	Richard F. Pops	Director	Sell	15,000	$132.47	$1,987,050.00	29,512
2/13/2024	Eiry Roberts	Insider	Sell	1,114	$132.96	$148,117.44	23,716
2/13/2024	Kevin Charles Gorman	CEO	Sell	2,832	$133.02	$376,712.64	514,596
2/13/2024	Matt Abernethy	CFO	Sell	1,352	$132.85	$179,613.20	31,528
2/8/2024	David W. Boyer	Insider	Sell	1,328	$135.41	$179,824.48	4,895
2/8/2024	Kevin Charles Gorman	CEO	Sell	2,274	$134.15	$305,057.10	506,962
2/8/2024	Matt Abernethy	CFO	Sell	980	$134.21	$131,525.80	30,314
2/6/2024	David W. Boyer	Insider	Sell	456	$141.96	$64,733.76	4,894
2/6/2024	Kevin Charles Gorman	CEO	Sell	3,040	$142.18	$432,227.20	504,919
2/6/2024	Matt Abernethy	CFO	Sell	1,280	$142.19	$182,003.20	29,434
1/31/2024	Eiry Roberts	Insider	Sell	1,457	$140.79	$205,131.03	20,832
1/31/2024	Kevin Charles Gorman	CEO	Sell	2,707	$140.69	$380,847.83	502,188
1/31/2024	Matt Abernethy	CFO	Sell	1,283	$140.72	$180,543.76	28,284
1/22/2024	Darin Lippoldt	Insider	Sell	10,000	$139.86	$1,398,600.00	35,882
1/8/2024	Kevin Charles Gorman	CEO	Sell	105,835	$132.44	$14,016,787.40	499,754
1/2/2024	Kyle Gano	Insider	Sell	75,000	$131.47	$9,860,250.00	130,250
1/2/2024	William H. Rastetter	Director	Sell	11,044	$131.47	$1,451,954.68	51,741
12/22/2023	Eiry Roberts	Insider	Sell	10,000	$126.74	$1,267,400.00	19,521
12/12/2023	Eiry Roberts	Insider	Sell	13,925	$120.30	$1,675,177.50	29,521
12/8/2023	Eiry Roberts	Insider	Sell	300	$120.10	$36,030.00	29,521
12/6/2023	Darin Lippoldt	Insider	Sell	20,830	$119.86	$2,496,683.80	35,882
12/1/2023	Gary A. Lyons	Director	Sell	5,000	$116.77	$583,850.00	203,697
11/29/2023	Jude Onyia	Insider	Sell	2,331	$113.57	$264,731.67	11,732
11/27/2023	Darin Lippoldt	Insider	Sell	10,919	$112.27	$1,225,876.13	35,882
10/2/2023	David W. Boyer	Insider	Sell	1,437	$112.68	$161,921.16	4,894
9/12/2023	Gary A. Lyons	Director	Sell	5,000	$115.02	$575,100.00	203,697
9/1/2023	Gary A. Lyons	Director	Sell	5,000	$110.06	$550,300.00	203,697
9/1/2023	Julie Cooke	Insider	Sell	824	$110.93	$91,406.32	17,263
8/30/2023	David W. Boyer	Insider	Sell	2,733	$107.60	$294,070.80	3,460
8/28/2023	Ingrid Delaet	Insider	Sell	1,431	$107.52	$153,861.12	5,931
8/21/2023	Jude Onyia	Insider	Sell	3,198	$107.37	$343,369.26	9,638
8/21/2023	Kevin Charles Gorman	CEO	Sell	9,328	$107.40	$1,001,827.20	499,754
8/21/2023	Matt Abernethy	CFO	Sell	2,132	$107.39	$228,955.48	27,131

SEC Filings (Institutional Ownership Changes) for Neurocrine Biosciences (NASDAQ:NBIX)

92.59% of Neurocrine Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Neurocrine Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/4/2026	AMG National Trust Bank	11,797	$1.55M	0.0%	-4.3%	0.012%
5/4/2026	State of Michigan Retirement System	24,181	$3.19M	0.0%	+2.5%	0.024%
5/4/2026	Principal Financial Group Inc.	238,161	$31.38M	0.0%	+5.2%	0.237%
5/4/2026	Chicago Partners Investment Group LLC	7,389	$0.97M	0.0%	+37.9%	0.007%
5/4/2026	Triglav Investments D.O.O.	9,000	$1.19M	0.1%	-10.0%	0.009%
5/2/2026	Diversify Wealth Management LLC	1,597	$0.21M	0.0%	N/A	0.002%
5/1/2026	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	25,146	$3.31M	0.0%	+0.8%	0.025%
5/1/2026	Citizens Financial Group Inc. RI	3,254	$0.43M	0.0%	N/A	0.003%
5/1/2026	Fifth Third Bancorp	27,393	$3.61M	0.0%	+3,070.5%	0.027%
5/1/2026	Candriam S.C.A.	275,064	$36.24M	0.2%	-6.2%	0.273%
5/1/2026	Sequoia Financial Advisors LLC	4,849	$0.64M	0.0%	-15.6%	0.005%
4/30/2026	Hsbc Holdings PLC	184,222	$24.30M	0.0%	+169.8%	0.183%
4/30/2026	Graetz Wealth LLC	1,868	$0.25M	0.2%	+14.1%	0.002%
4/30/2026	Azzad Asset Management Inc. ADV	8,777	$1.16M	0.1%	-2.6%	0.009%
4/30/2026	Sumitomo Mitsui Trust Group Inc.	220,449	$29.04M	0.0%	+8.8%	0.219%
4/30/2026	Resona Asset Management Co. Ltd.	43,522	$5.72M	0.0%	-10.1%	0.043%
4/30/2026	Oregon Public Employees Retirement Fund	20,584	$2.71M	0.0%	+3.3%	0.020%
4/29/2026	Navalign LLC	3,069	$0.40M	0.1%	-15.0%	0.003%
4/29/2026	Jackson Thornton Wealth Management LLC	3,260	$0.42M	0.0%	-7.1%	0.003%
4/29/2026	Burney Co.	5,321	$0.70M	0.0%	-38.8%	0.005%
4/29/2026	Swedbank AB	579,429	$76.33M	0.1%	-0.8%	0.576%
4/28/2026	Collaborative Fund Advisors LLC	3,293	$0.43M	0.3%	N/A	0.003%
4/28/2026	Ascentis Independent Advisors	305	$40K	0.0%	N/A	0.000%
4/28/2026	Stephens Inc. AR	2,356	$0.31M	0.0%	N/A	0.002%
4/28/2026	AdvisorShares Investments LLC	7,170	$0.95M	0.2%	+21.5%	0.007%
4/28/2026	Praxis Investment Management Inc.	3,011	$0.40M	0.0%	+7.5%	0.003%
4/28/2026	QRG Capital Management Inc.	16,519	$2.18M	0.0%	+1.9%	0.016%
4/27/2026	Simplify Asset Management Inc.	2,505	$0.33M	0.0%	-26.4%	0.002%
4/27/2026	HB Wealth Management LLC	7,286	$0.96M	0.0%	+51.2%	0.007%
4/27/2026	Moran Wealth Management LLC	23,506	$3.10M	0.1%	N/A	0.023%
4/27/2026	PAX Financial Group LLC	2,934	$0.39M	0.1%	-12.0%	0.003%
4/27/2026	New York State Teachers Retirement System	89,710	$11.82M	0.0%	-6.2%	0.089%
4/27/2026	Fjarde AP Fonden Fourth Swedish National Pension Fund	64,223	$8.46M	0.0%	+82.3%	0.064%
4/27/2026	Fideuram Intesa Sanpaolo Private Banking S.P.A.	12,643	$1.67M	0.1%	-3.9%	0.013%
4/25/2026	Strs Ohio	12,316	$1.62M	0.0%	+430.9%	0.012%
4/25/2026	Keybank National Association OH	2,617	$0.35M	0.0%	-7.6%	0.003%
4/24/2026	Root Financial Partners LLC	1,154	$0.15M	0.0%	+479.9%	0.001%
4/24/2026	Essex Financial Services Inc.	1,838	$0.24M	0.0%	+19.7%	0.002%
4/24/2026	Fulton Bank N.A.	4,652	$0.61M	0.0%	+13.7%	0.005%
4/24/2026	IFM Investors Pty Ltd	21,155	$2.79M	0.0%	-0.8%	0.021%
4/24/2026	MQS Management LLC	2,471	$0.33M	0.2%	+21.0%	0.002%
4/23/2026	SJS Investment Consulting Inc.	341	$45K	0.0%	+67.2%	0.000%
4/23/2026	Inspire Investing LLC	2,555	$0.34M	0.0%	+9.2%	0.003%
4/23/2026	waypoint wealth counsel	2,869	$0.38M	0.2%	-13.1%	0.003%
4/23/2026	Continuum Advisory LLC	44,068	$5.81M	0.6%	+3.6%	0.044%
4/22/2026	Janney Montgomery Scott LLC	10,764	$1.42M	0.0%	-2.5%	0.011%
4/22/2026	Pictet Asset Management Holding SA	602,643	$78.95M	0.1%	-22.4%	0.599%
4/22/2026	Sterling Capital Management LLC	1,061	$0.14M	0.0%	-25.3%	0.001%
4/22/2026	Ground Swell Capital LLC	3,767	$0.50M	1.0%	N/A	0.004%
4/21/2026	Louisiana State Employees Retirement System	29,100	$3.83M	0.1%	N/A	0.029%
4/20/2026	Ritholtz Wealth Management	1,697	$0.22M	0.0%	+11.6%	0.002%
4/20/2026	Blue Trust Inc.	535	$70K	0.0%	+5,844.4%	0.001%
4/20/2026	Davis Investment Partners LLC	4,459	$0.59M	0.2%	+8.0%	0.004%
4/20/2026	Fifth Third Wealth Advisors LLC	3,563	$0.47M	0.0%	+13.7%	0.004%
4/20/2026	OP Asset Management Ltd	18,506	$2.44M	0.0%	N/A	0.018%
4/20/2026	Assenagon Asset Management S.A.	91,478	$12.05M	0.0%	+14.3%	0.091%
4/17/2026	Krilogy Financial LLC	8,540	$1.10M	0.0%	-25.4%	0.008%
4/17/2026	Paragon Capital Management Inc.	9,954	$1.31M	1.1%	N/A	0.010%
4/17/2026	PKO Investment Management Joint Stock Co	1,400	$0.18M	0.0%	+7.7%	0.001%
4/17/2026	Brookstone Capital Management	5,050	$0.67M	0.0%	+23.1%	0.005%
4/16/2026	SG Americas Securities LLC	59,267	$7.81M	0.0%	-55.9%	0.059%
4/16/2026	Evolve Private Wealth LLC	6,223	$0.82M	0.0%	-19.0%	0.006%
4/16/2026	BI Asset Management Fondsmaeglerselskab A S	4,497	$0.59M	0.0%	-42.4%	0.004%
3/17/2026	Rockefeller Capital Management L.P.	281,320	$39.90M	0.1%	+45.0%	0.280%
3/9/2026	Corient Private Wealth LLC	5,357	$0.76M	0.0%	+33.8%	0.005%
3/6/2026	Hsbc Holdings PLC	68,292	$9.69M	0.0%	-62.8%	0.068%
3/3/2026	Caitong International Asset Management Co. Ltd	1,551	$0.22M	0.1%	N/A	0.002%
3/2/2026	Wick Capital Partners LLC	1,579	$0.22M	0.0%	N/A	0.002%
2/25/2026	MidFirst Bank	1,239	$0.18M	0.0%	N/A	0.001%
2/24/2026	Pacer Advisors Inc.	29,621	$4.20M	0.0%	+121.6%	0.030%
2/23/2026	Kera Capital Partners Inc.	2,188	$0.30M	0.0%	+26.3%	0.002%
2/23/2026	Virtu Financial LLC	15,389	$2.18M	0.1%	+775.9%	0.015%
2/20/2026	Wick Capital Partners LLC	8,054	$1.14M	0.1%	N/A	0.008%
2/19/2026	Invesco Ltd.	343,421	$48.71M	0.0%	+6.1%	0.342%
2/19/2026	Corient Private Wealth LLC	7,292	$1.03M	0.0%	+82.1%	0.007%
2/18/2026	Mercer Global Advisors Inc. ADV	40,957	$5.81M	0.0%	+29.6%	0.041%
2/18/2026	Summit Global Investments	24,804	$3.52M	0.2%	-31.4%	0.025%
2/18/2026	Vident Advisory LLC	1,631	$0.23M	0.0%	-11.9%	0.002%
2/18/2026	State of Tennessee Department of Treasury	33,807	$4.60M	0.0%	-4.1%	0.034%
2/18/2026	EP Wealth Advisors LLC	2,949	$0.42M	0.0%	N/A	0.003%
2/18/2026	Mackenzie Financial Corp	76,840	$10.81M	0.0%	-9.5%	0.077%
2/18/2026	NewEdge Advisors LLC	12,998	$1.84M	0.0%	+5.5%	0.013%
2/18/2026	Empowered Funds LLC	4,366	$0.62M	0.0%	-76.8%	0.004%
2/18/2026	XTX Topco Ltd	11,775	$1.67M	0.0%	+326.3%	0.012%
2/18/2026	Zurich Insurance Group Ltd FI	459,437	$65.16M	0.5%	N/A	0.458%
2/18/2026	Virtus Investment Advisers LLC	4,472	$0.63M	0.2%	+25.8%	0.004%
2/18/2026	Wellington Management Group LLP	1,744,560	$247.43M	0.1%	-3.7%	1.738%
2/18/2026	Toronto Dominion Bank	15,883	$2.25M	0.0%	-1.3%	0.016%
2/18/2026	Tudor Investment Corp ET AL	19,524	$2.77M	0.0%	-27.3%	0.019%
2/18/2026	Twinbeech Capital LP	3,110	$0.44M	0.0%	N/A	0.003%
2/18/2026	Polymer Capital Management US LLC	6,868	$0.97M	0.1%	N/A	0.007%
2/18/2026	Orbimed Advisors LLC	314,240	$44.57M	0.9%	-11.1%	0.313%
2/18/2026	Oxford Asset Management LLP	2,101	$0.30M	0.1%	N/A	0.002%
2/18/2026	Perceptive Advisors LLC	331,050	$46.95M	0.8%	-26.4%	0.330%
2/18/2026	Millennium Management LLC	442,866	$62.81M	0.0%	-52.2%	0.441%
2/18/2026	Man Group plc	231,210	$32.79M	0.1%	+186.0%	0.230%
2/18/2026	Inspire Investing LLC	2,340	$0.33M	0.0%	+6.8%	0.002%
2/18/2026	Investment Management Corp of Ontario	6,659	$0.94M	0.0%	+43.4%	0.007%
2/18/2026	Janus Henderson Group PLC	459,176	$65.13M	0.0%	-22.8%	0.458%
2/18/2026	Gotham Asset Management LLC	168,572	$23.91M	0.1%	+23.6%	0.168%

Data available starting January 2016

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy in pediatrics and adults; NBI-921352 to treat developmental and epileptic encephalopathy syndrome in pediatrics and adults; NBI-827104 to treat epileptic encephalopathy with continuous spike-and-wave during sleep; NBI-1076986 to treat movement disorders; crinecerfront to treat congenital adrenal hyperplasia in adults and children; EFMODY to treat congenital adrenal hyperplasia and adrenal insufficiency in adults; valbenazine for the adjunctive treatment of schizophrenia; NBI-1065845 for the treatment of inadequate response to treatment in major depressive disorder; luvadaxistat to treat cognitive impairment related to schizophrenia; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; NBI-1117570 for the treatment of symptoms of psychosis and cognition in neurological and neuropsychiatric conditions; and NBI-1117569, NBI-1117567, and NBI-1065890 to treat CNS indications. The company also has license and collaboration agreements with Heptares Therapeutics Limited; Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Today's Range

Now: $134.07

$131.78

$134.66

50 Day Range

MA: $130.25

$126.32

$133.44

52 Week Range

Now: $134.07

$108.35

$160.18

Volume

1,196,435 shs

Average Volume

1,179,319 shs

Market Capitalization

$13.48 billion

P/E Ratio

28.77

Dividend Yield

N/A

Beta

0.34

Who are the company insiders with the largest holdings of Neurocrine Biosciences?: Neurocrine Biosciences' top insider shareholders include:
Neurocrine Biosciences Inc (Major Shareholder)
Kevin Charles Gorman (CEO)
Kevin Charles Gorman (Director)
Gary A Lyons (Director)
Gary A Lyons (Director)
Haig P Bozigian (Insider)
Darin Lippoldt (Insider)
Dimitri E Grigoriadis (Insider)
Kyle Gano (CEO)
Timothy P Coughlin (CFO)
Learn More about top insider investors at Neurocrine Biosciences.
Who are the major institutional investors of Neurocrine Biosciences?: Neurocrine Biosciences' top institutional investors include:
Pictet Asset Management Holding SA — 0.60%
Swedbank AB — 0.58%
Candriam S.C.A. — 0.27%
Principal Financial Group Inc. — 0.24%
Sumitomo Mitsui Trust Group Inc. — 0.22%
Hsbc Holdings PLC — 0.18%
Learn More about top institutional investors of Neurocrine Biosciences stock.
Which institutional investors are selling Neurocrine Biosciences stock?: During the previous quarter, NBIX stock was sold by these institutional investors:
Pictet Asset Management Holding SA
SG Americas Securities LLC
Candriam S.C.A.
New York State Teachers Retirement System
Resona Asset Management Co. Ltd.
Swedbank AB
Burney Co.
BI Asset Management Fondsmaeglerselskab A S
During the previous year, company insiders that have sold Neurocrine Biosciences company stock include:
Kevin Charles Gorman (Director)
Kyle Gano (CEO)
Darin Lippoldt (Insider)
William H Rastetter (Director)
Jude Onyia (Insider)
Leslie V Norwalk (Director)
George J Morrow (Director)
Ingrid Delaet (Insider)
Learn More investors selling Neurocrine Biosciences stock.
Which institutional investors are buying Neurocrine Biosciences stock?: Within the previous quarter, NBIX stock was bought by institutional investors including:
Hsbc Holdings PLC
Louisiana State Employees Retirement System
Fjarde AP Fonden Fourth Swedish National Pension Fund
Fifth Third Bancorp
Moran Wealth Management LLC
OP Asset Management Ltd
Sumitomo Mitsui Trust Group Inc.
Principal Financial Group Inc.